NeuroBo Pharmaceuticals Common Stock

NeuroBo Pharmaceuticals (NRBO) currently reports a common stock of $7K as of June 2026. That compares with $24K in the prior-year period — down 70.8% year over year. Use the charts on this page to explore NeuroBo Pharmaceuticals's common stock history and peer comparisons.

NeuroBo Pharmaceuticals's common stock decreased from $24K to $7K — a 70.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroBo Pharmaceuticals reported $7K in common stock as of June 2026. That compares with $24K in the prior-year period — down 70.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $7K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroBo Pharmaceuticals, and consider following NRBO for alerts when major investors trade the stock.

NeuroBo Pharmaceuticals is classified in the Healthcare sector. On common stock, it currently shows $7K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NRBO with unrelated industries.